BIOLINE RX (Israel) Today

Equity ratings for BIOLINE RX LTD are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 27th of August 2021 and ending today, the 26th of September 2021. Click here to learn more.
BIOLINE RX LTD cannot be verified against its exchange. It appears that BIOLINE RX is not available for investing at the moment. Please verify the symbol is currently traded on Tel Aviv Stock Exchange. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.
Refresh

BIOLINE RX Stock Profile

BioLineRx Ltd., a clinical stage biopharmaceutical development company, focuses on oncology and immunology. BioLineRx Ltd. was founded in 2003 and is based in Modiin, Israel. BIOLINE RX operates under Biotechnology classification in Israel and is traded on Tel Aviv Stock Exchange. It employs 48 people.. The public information regarding BIOLINE RX LTD's current market price is not available at this time.
BIOLINE RX LTD is not yet fully synchronised with the market data
BIOLINE RX LTD has some characteristics of a very speculative penny stock
Net Loss for the year was (22.92 M).
BIOLINE RX LTD has accumulated about 40.61 M in cash with (22.01 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.28.
Legal NameBIOLINE RX LTD
CEOKinneret Savitsky  (View All)
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of BIOLINE RX's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Not RatedUndervalued
BIOLINE RX LTD (BLRX) is traded on Tel Aviv Stock Exchange in Israel and employs 48 people. The company currently falls under 'Large-Cap' category with current market capitalization of 13.07 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate BIOLINE RX's market, we take the total number of its shares issued and multiply it by BIOLINE RX's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. BIOLINE RX LTD operates under Healthcare sector and is part of Biotechnology industry. The entity has 146.55 M outstanding shares. BIOLINE RX LTD has accumulated about 40.61 M in cash with (22.01 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.28.
Check BIOLINE RX Probability Of Bankruptcy

BIOLINE Stock Against Markets

Picking the right benchmark for BIOLINE RX stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in BIOLINE RX stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for BIOLINE RX is critical whether you are bullish or bearish towards BIOLINE RX LTD at a given time.
BIOLINE RX LTD cannot be verified against its exchange. It appears that BIOLINE RX is not available for investing at the moment. Please verify the symbol is currently traded on Tel Aviv Stock Exchange. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.
Refresh

Try Other Stock Suggestions

View Currently Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with BIOLINE RX stock to make a market-neutral strategy. Peer analysis of BIOLINE RX could also be used in its relative valuation, which is a method of valuing BIOLINE RX by comparing valuation metrics with similar companies.

BIOLINE RX Corporate Directors

BIOLINE RX corporate directors refer to members of a BIOLINE RX board of directors. The board of directors generally takes responsibility for the BIOLINE RX's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of BIOLINE RX's board members must vote for the resolution. The BIOLINE RX board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
Sandra Panem - DirectorProfile
Avraham Molcho - External DirectorProfile
Mali Zeevi - Finance DirectorProfile
Jacob Friedman - DirectorProfile
Check out Trending Equities. Note that the BIOLINE RX LTD information on this page should be used as a complementary analysis to other BIOLINE RX's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Global Correlations module to find global opportunities by holding instruments from different markets.

Other Tools for BIOLINE Stock

When running BIOLINE RX LTD price analysis, check to measure BIOLINE RX's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BIOLINE RX is operating at the current time. Most of BIOLINE RX's value examination focuses on studying past and present price action to predict the probability of BIOLINE RX's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move BIOLINE RX's price. Additionally, you may evaluate how the addition of BIOLINE RX to your portfolios can decrease your overall portfolio volatility.
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Go
Fundamental Analysis
View fundamental data based on most recent published financial statements
Go
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Go
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Go
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Go
CEO Directory
Screen CEOs from public companies around the world
Go
Global Correlations
Find global opportunities by holding instruments from different markets
Go
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Go
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Go
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Go